{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:31Z","timestamp":1787024551613,"version":"build-2736575974"},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.2169\/internalmedicine.5102-20","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T18:07:21Z","timestamp":1604167641000},"page":"2653-2660","source":"Crossref","is-referenced-by-count":16,"title":["Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus"],"prefix":"10.2169","volume":"59","author":[{"given":"Tatsuki","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"},{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamitsu","family":"Miyaaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Motoyoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Yamashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Yamamichi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsurou","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryouhei","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kuribayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naota","family":"Taura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Huang CF, Iio E, Jun DW, et al. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatol Int 13: 587-598, 2019."},{"key":"2","unstructured":"2. Carrat F, Fontaine H, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 6736: 1-12, 2019."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chhatwal J, He T, Hur C, et al. Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving. Clin Gastroenterol Hepatol 15: 827-837.e8, 2017.","DOI":"10.1016\/j.cgh.2016.09.015"},{"key":"4","unstructured":"4. He T, Lopez-Olivo MA, Hur C, et al. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Aliment Pharmacol Ther 46: 711-721, 2017."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kaishima T, Akita T, Ohisa M, et al. Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture. Japan Hepatol Res 48: 509-520, 2018.","DOI":"10.1111\/hepr.13053"},{"key":"6","unstructured":"6. Evon DM, Stewart PW, Amador J, et al. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One 13: 1-26, 2018."},{"key":"7","unstructured":"7. Evon DM, Sarkar S, Amador J, et al. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study. J Hepatol 71: 486-497, 2019."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Saeed S, Moodie EEM, Strumpf E, et al. Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV\/Hepatitis C co-infected individuals. J Viral Hepat 25: 1507-1514, 2018.","DOI":"10.1111\/jvh.12985"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ichikawa T, Miyaaki H, Miuma S, et al. Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antivirals. Hepatol Res 48: 1-8, 2017.","DOI":"10.1111\/hepr.12974"},{"key":"10","unstructured":"10. van Vugt JLA, Alferink LJM, Buettner S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort. J Hepatol 68: 707-714, 2018."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohashi K, Ishikawa T, Imai M, et al. Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease. Eur J Gastroenterol Hepatol 31: 1, 2019.","DOI":"10.1097\/MEG.0000000000001415"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tsekoura M, Kastrinis A, Katsoulaki M, et al. Sarcopenia and its impact on quality of life. In: Advances in Experimental Medicine and Biology. 2017: 213-218.","DOI":"10.1007\/978-3-319-57379-3_19"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takata R, Nishikawa H, Enomoto H, et al. Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease. Medicine (Baltimore) 96: 1-8, 2017.","DOI":"10.1097\/MD.0000000000008761"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gowda C, Compher C, Amorosa VK, et al. Association between chronic hepatitis C virus infection and low muscle mass in U.S. adults. J Viral Hepat 21: 938-943, 2014.","DOI":"10.1111\/jvh.12273"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sugimoto R, Iwasa M, Hara N, et al. Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection. Hepatol Res 48: 337-344, 2018.","DOI":"10.1111\/hepr.12999"},{"key":"16","unstructured":"16. Kashani KB, Frazee EN, Kukr\u00e1lov\u00e1 L, et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med 45: 1-7, 2016."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim SW, Jung HW, Kim CH, et al. A new equation to estimate muscle mass from creatinine and cystatin C. PLoS One 11: 1-9, 2016.","DOI":"10.1371\/journal.pone.0148495"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ichikawa T, Miyaaki H, Miuma S, et al. Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease. Biomed REPORTS 12: 89-98, 2020.","DOI":"10.3892\/br.2020.1273"},{"key":"19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"19. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545, 1991.","journal-title":"SLEEP","ISSN":"https:\/\/id.crossref.org\/issn\/0161-8105","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Doi Y, Minowa M, Uchiyama M, et al. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 97: 165-172, 2000.","DOI":"10.1016\/S0165-1781(00)00232-8"},{"key":"21","unstructured":"21. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101-119, 2003."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 32: 959-976, 2002.","DOI":"10.1017\/S0033291702006074"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ichikawa T, Miyaaki H, Miuma S, et al. Carotid intima-media thickness and small dense low-density lipoprotein cholesterol increase after one year of treatment with direct-acting antivirals in patients with hepatitis C virus infection. Intern Med 58: 1209-1215, 2019.","DOI":"10.2169\/internalmedicine.1514-18"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest. Hepatology 46: 32-36, 2007.","DOI":"10.1002\/hep.21669"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63: 131-140, 2015.","DOI":"10.1016\/j.jhep.2015.02.031"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yoshimura E, Ichikawa T, Miyaaki H, et al. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy. Biomed Rep 5: 193-198, 2016.","DOI":"10.3892\/br.2016.702"},{"key":"28","unstructured":"28. Ichikawa T, Miyaaki H, Miuma S, et al. Calculated body muscle mass as a useful screening marker for low skeleton muscle mass and sarcopenia in chronic liver disease. Hepatol Res 2020: hepr.13492, 2020."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ioannou GN, Feld JJ. What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection? Gastroenterology 156: 446-460.e2, 2019.","DOI":"10.1053\/j.gastro.2018.10.033"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nipp RD, Fuchs G, El-Jawahri A, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 23: 97-104, 2018.","DOI":"10.1634\/theoncologist.2017-0255"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Bonkovsky HL, Snow KK, Malet PF, et al. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol 46: 420-431, 2007.","DOI":"10.1016\/j.jhep.2006.10.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sung JC, Bosh C, Wyatt B, et al. Hepatitis C cure improved patient-reported outcomes in patients with and without liver fibrosis in a prospective study at a large urban medical center. J Viral Hepat 27: 350-359, 2020.","DOI":"10.1111\/jvh.13234"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Matsuzaki T, Ichikawa T, Kondo H, et al. Prevalence of restless legs syndrome in Japanese patients with chronic liver disease. Hepatol Res 42: 1221-1226, 2012.","DOI":"10.1111\/j.1872-034X.2012.01043.x"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 45: 295-300, 1999.","DOI":"10.1136\/gut.45.2.295"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5102-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:49:35Z","timestamp":1604702975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_5102-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":34,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5102-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}